Technology type 'Technology Type'
No parent terms
Technology Type
Binding (0) | Electrophoresis (0) | Molecule Labelling (0) | Imaging (0) | Chromatography (0) | Immunostaining (1) | Sequencing (0) | Microarray (0) | Flow Cytometry (0) | Enzymatic Activity Measurements (0) | PCR (0) | Mass Spectrometry (0) | Spectrophotometry (0) | Chemostat Measurement (0) | Structural Methods (0) | Mathematical Model Type (0) | CRISPR gene modulation (0)
Technology Type
Binding (0) | Electrophoresis (0) | Molecule Labelling (0) | Imaging (0) | Chromatography (0) | Immunostaining (1) | Sequencing (0) | Microarray (0) | Flow Cytometry (0) | Enzymatic Activity Measurements (0) | PCR (0) | Mass Spectrometry (0) | Spectrophotometry (0) | Chemostat Measurement (0) | Structural Methods (0) | Mathematical Model Type (0) | CRISPR gene modulation (0)
Related assays
1 Assays visible to you, out of a total of 18Treat MCF10A cells (in duplicate) with dilution series of LJH685 (Stock in DMSO): 100µM, 33µM, 10µM, 3µM, 1µM, 0.3µM, 0.1µM, 0µM (control) +/- 3ng/ml EGF for 30 min. Total of 32 samples. Extract and quantify activated Ras activity levels by ELISA.
Expected results: We expect to see an increase in Ras activity as we increase the concentrations of LJH685. We should see this increase in both the presence and absence of EGF but see a much stronger effect with EGF. The 30 min sample time should be ...
Submitter: Steven Wiley
Assay type: Inhibitor study
Technology type: ELISA
Investigation: 1 hidden item
Study: 1 hidden item